Publication & Citation Trends
Most Cited Works
Publications
208 total
373 Enhancement of TCR-engineered T-cells targeting MAGE-A4 antigen by co-expression of CD8α and inhibition of AKT signaling during ex vivo T-cell expansion OA
Cited by 1
Semantic Scholar
976TiP SPEARHEAD-2 trial design: A phase II pilot trial of ADP-A2M4 in combination with pembrolizumab in patients with recurrent or metastatic head and neck cancer OA
Cited by 4
Semantic Scholar
379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor
Cited by 11
Semantic Scholar
95 Inhibition of AKT signaling during expansion of TCR-engineered T-cells from patient leukocyte material generates SPEAR T-cells with enhanced functional potential in vitro
Cited by 1
Semantic Scholar
Challenges and progress in lentiviral vector bioprocessing
Cited by 1
Semantic Scholar
Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response OA
Cited by 116
Semantic Scholar
An Innovative in Vitro Potency Assay Designed to Predict the Fate of Chimeric Antigen Receptors Modified T Cell Therapy Post Infusion in ALL OA
Cited by 0
Semantic Scholar
A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma OA
Cited by 55
Semantic Scholar
Research Topics
CAR-T cell therapy research
(166)
Immunotherapy and Immune Responses
(135)
Virus-based gene therapy research
(58)
Immune Cell Function and Interaction
(41)
Cancer Immunotherapy and Biomarkers
(40)
Frequent Co-Authors
Affiliations
University of the Sciences
Sprint (United States)
Cincinnati Children's Hospital Medical Center
National Institutes of Health
Pfizer (United Kingdom)